Facile and green synthesis of a hydrophilic imprinted resin in a deep eutectic solvent–water medium for the specific molecular recognition of tumor biomarkers in complex biological matrices-Reference-Cited by-同舟云学术

Facile and green synthesis of a hydrophilic imprinted resin in a deep eutectic solvent–water medium for the specific molecular recognition of tumor biomarkers in complex biological matrices

Published:2024 Issue: Volume: Page:
ISSN:1463-9262
Container-title:Green Chemistry
language:en
Short-container-title:Green Chem.

Author:

Wang Mingwei¹,Zhou Liang¹,Qiao Fengxia²,Yan Hongyuan¹³^ORCID

Affiliation:

1. Hebei Key Laboratory of Public Health Safety, College of Pharmaceutical Science, College of Chemistry and Materials Science, Hebei University, Baoding 071002, China

2. College of Biochemical and Environmental Engineering, Baoding University, Baoding, 071002, China

3. State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Hebei University, Baoding 071002, China

Abstract

A novel and environmentally friendly strategy was developed to synthesize a hydrophilic molecularly imprinted resin in a deep eutectic solvent–water medium, achieving exceptional molecular recognition of tumor biomarkers in complex biological sample.

Funder

Hebei University

Department of Education of Hebei Province

Natural Science Foundation of Hebei Province

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Pollution,Environmental Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2024/GC/D3GC04207C

Reference55 articles.

1. Metal-free bioorthogonal click chemistry in cancer theranostics

2. Enzyme-free isothermal amplification strategy for the detection of tumor-associated biomarkers: A review

3. Emerging tumor-on-chips with electrochemical biosensors

4. Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

5. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation